CN101357206A - Medicine for treating liver cancer and preparation method thereof - Google Patents
Medicine for treating liver cancer and preparation method thereof Download PDFInfo
- Publication number
- CN101357206A CN101357206A CNA2008101431663A CN200810143166A CN101357206A CN 101357206 A CN101357206 A CN 101357206A CN A2008101431663 A CNA2008101431663 A CN A2008101431663A CN 200810143166 A CN200810143166 A CN 200810143166A CN 101357206 A CN101357206 A CN 101357206A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- radix
- herba
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a medicine for treating liver cancer and a preparation method thereof, and the medicine is mainly prepared by bile powder, rhubarb, japanese ardisia, concha arcae, spirifer, uniflower swisscentaury root, herba artemisiae capillaries, lucid ganoderma, herba scutellariae barbatae, rhizoma zedoariae, frankincense, pangolin, knoxia valerianoides, spreading hedyotis herb, salvia miltiorrhiza and radix astragali. The preparation method is that the 16 medicines are soaked by 10 times of water for 2 hours, the medicines together with the water firstly are decocted for 15-20 minutes to the temperature of 100 DEG C by high heat, and then are decocted for 40-50 minutes by slow fire to be cooled bellow 40 DEG C for extracting juice, removing slag and clarification; clear solution is taken to be concentrated by two third to be prepared into ointment, or the clear solution is put into a drying cabinet with the temperature of 80-90 DEG C to be dried for 8-9 hours, and then the dried clear solution is taken out to be prepared into pulvis. The medicine has strong penetrability, can quickly permeate into cancer cell, can effectively prevent the catastrophe, shift and spread of the cancer cell, and has restoration effects on liver cell without toxic and side effect; the treating effect reaches 96.6%.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of hepatocarcinoma, the invention still further relates to the preparation method of this medicine.
Background technology
Present hepatocarcinoma serious threat human life, the human cancer complexion changed of talking, cancer has become the synonym of incurable disease, and with the change of living environment and quality of life become more diverse, complicated, variationization, number of patients and morbidity risk rate are linearly soaring, and the haze of cancer is being shrouded in the life sky.The mankind have paid unremitting effort in order to conquer it, though spent the most expensive cost, but still the three big therapys that rest on radiotherapy, chemotherapy and excision then go up, and the medicine of use is also mostly to be product for the treatment of the poisonous disease with poisonous drugs, and toxic and side effects is big, even His merit cannot offset his faults, and the labor life is lost money.Treatment by Chinese herbs before how with the medicine of low-grades such as Rhizoma Paridis, Mylabris, Scolopendra, worm scorpion, is sent an expedition against overweightly, turns round and look at this and hinders that, and treatment hepatocarcinoma lacks real effective medicine.
Summary of the invention
The purpose of this invention is to provide and a kind ofly can treat hepatocarcinoma rapidly, and effectively prevent the medicine that is used for the treatment of hepatocarcinoma that hepatoma carcinoma cell transfer, diffusion, pure Chinese herbal medicine without any side effects are made.Another object of the present invention just provides the preparation method of this medicine.
Solution of the present invention is on the basis according to handed down from the older generations of the family hundreds of years secret recipes, year research and tens thousand of clinical experience prescription develop surplus inventor nearly 40, in preparation process, quality standard, stability, pharmacodynamics, clinical experiment, form through repeatedly clinical screening.The pharmaceutical formulation of making by following traditional Chinese medicines material weight proportion.
Medicine of the present invention is made by following Chinese crude drug materials of weight proportions medicine:
Gallbladder powder 4-9 part Radix Et Rhizoma Rhei 14-26 part PINGDIMU 24-34 part
Concha Arcae 14-26 part Fossilia Spiriferis 6-14 part Radix Rhapontici 14-26 part
Herba Artemisiae Scopariae 14-26 part Ganoderma 14-26 part Herba Scutellariae Barbatae 24-34 part
Rhizoma Curcumae 6-14 part Olibanum 6-14 part Squama Manis 14-26 part
Radix Knoxiae 14-26 part Herba Hedyotidis Diffusae 14-26 part
Radix Salviae Miltiorrhizae 11-19 part Radix Astragali 14-26 part
Each crude drug ratio range of the present invention is:
Gallbladder powder 5-8 part Radix Et Rhizoma Rhei 16-24 part PINGDIMU 26-32 part
Concha Arcae 16-24 part Fossilia Spiriferis 8-12 part Radix Rhapontici 16-24 part
Herba Artemisiae Scopariae 16-24 part Ganoderma 16-24 part Herba Scutellariae Barbatae 26-32 part
Rhizoma Curcumae 8-12 part Olibanum 8-12 part Squama Manis 16-24 part
Radix Knoxiae 16-24 part Herba Hedyotidis Diffusae 16-24 part
Radix Salviae Miltiorrhizae 13-17 part Radix Astragali 16-24 part
Each crude drug weight proportion of medicine of the present invention is:
30 parts of 20 parts of PINGDIMU of 6 parts of Radix Et Rhizoma Rhei of gallbladder powder
20 parts of 10 parts of Radix Rhapontici of 20 parts of Fossilia Spiriferiss of Concha Arcae
30 parts of 20 portions of Herba Scutellariae Barbataes of 20 portions of Ganodermas of Herba Artemisiae Scopariae
20 parts of 10 parts of Squama Maniss of 10 parts of Olibanums of Rhizoma Curcumae
20 parts of 20 parts of Herba Hedyotidis Diffusaes of Radix Knoxiae
20 parts of 5 parts of Radixs Astragali of Radix Salviae Miltiorrhizae
The said gallbladder powder of medicine of the present invention is to be refined by the bile of duck, goose, pig, cattle to form.Medicine of the present invention is unguentum or powder or capsule or pill.
The preparation method of medicine of the present invention: a, take by weighing each raw material by recipe ratio; B, with above 16 herbal medicines with the water logging of 10 times of amounts bubble 120 minutes; C is put frying pan or decocting machine with soaked medicine together with water, decoct with high heat earlier 100 degrees centigrade 15-20 minute, use slow fire boiling 40-50 minute then; Be cooled to below 40 degrees centigrade the narrow juice in back, get clear liquid after removing slag, clarifying; D, clear liquid is concentrated 2/3 make unguentum, or clear liquid was put into 80-90 degree centigrade of drying baker inner drying 8-9 hour, take out the back and pulverize, make powder or electuary or pill; E, the powder made dress sealed into the capsule of 0.5g/ grain.
The present invention shows that by clinical experience result repeatedly following advantage and curative effect are arranged:
1, to have a permeability strong for this medicine, can the rapid permeability cancerous cell, and divide and disintegrate tumor, and its malignant cell sharp separation is gone out body.
2, this medicine has the merit of reparation to hepatocyte, and the pain of dispelling detumescence, is set upright and got rid of evils strong QI and blood.
3, this pharmaceutical formulation is reasonable, unique, preparation technology is simple, and steady quality is without any side effects, thoroughly dissolves tumor, and effectively controlling symptoms prolongs life, improves life quality, and the treatment effective percentage reaches 96.6%.。
I am at Hunan Shaoyang City money river hospital treatment of cancer center, and the patient who chooses in October, 2007 to 2008 year hospitalization does clinical experiment, and all cases are confirmed as the cancer patient by the People's Hospital above the provincial level or tumour hospital.And behind radiotherapy, chemotherapy, excision, Ca shifts, the patients with advanced cancer of diffusion, according to my Therapeutic Method, stop to transfer from one hospital to another and control all treatments such as preceding radiotherapy, chemotherapy, disconnected clothes all medicines in early stage are taken medicine of the present invention, used part enhancing physical ability medicine and antibiotics transfusion instead in 3-7 days simultaneously, to alleviate the medicine transient response.Its usage and dosage such as following table:
| Time (my god) | Consumption (grain) | Inferior/day |
| 1-15 days | 8/ time | 6/ day |
| 16-30 days | 7/ time | 6/ day |
| 30-90 days | 7/ time | 4/ day |
| After the 90th day | 6/ time | 3/ day |
Take effect contrast table behind the medicine of the present invention with the Shaoyang City money river hospital 30 people's cases of seeing and treating patients below:
| Patient's example number (total number 30 people) | Proportion | Therapeutic outcome | Remarks |
| 29 | 96.6％ | Effectively | Controlling symptoms is improved life quality |
| 25 | 83.0％ | Produce effects | Prolong life more than 10 months |
| 16 | 53％ | Clinical cure | Symptom disappears substantially, does not have uncomfortable reaction |
| 1 | 0.03％ | Invalid | Symptom does not have change, therapy discontinued |
As 1, the yellow thin English of liver cancer patient that makes a definite diagnosis two the People's Hospitals through Guangxi, the woman, 83 years old, through taking medicine of the present invention after 33 days, patient's ordinary circumstance can, do not tell special discomfort, no angor does not have vomiting, vital sign is steady, abdominal part is put down soft, sb.'s illness took a favorable turn.
2, Liu Tiecheng, the man, 53 years old, hepatocarcinoma, cirrhotic ascites were made a definite diagnosis by hospital through the refined Annex III in Central South University Hunan, after taking medicine of the present invention after 44 days, ordinary circumstance can, vital signs is steady, abdominal part swelling is uncomfortable obviously to disappear, two lower limb do not have edema.
3, Yao Baikui, the man, 77 years old, be diagnosed as liver cirrhosis, later period of hepatocarcinoma through Hunan Province tumour hospital, take medicine of the present invention after 24 days, refreshing clear, appetite improvement, ascites disappears, and lower limb do not have obvious edema, and hepatalgia disappears, state of an illness recovery from illness.Early stage, symptom disappeared substantially
4, Zhao is with honor, the woman, 56 years old, make a definite diagnosis hepatocarcinoma and two lungs shift through Xiangya Hospital, Central-South China Univ., through taking medicine of the present invention after 40 days, ordinary circumstance can, vital sign is steady, upper right abdomen pain takes a turn for the better, the visible hematuria of no naked eyes, two lower limb do not have edema.。
5, Ceng Xiangbai, the man, 61 years old, be diagnosed as liver left side internal lobe malignant tumor through Hunan Province tumour hospital, multiple metastatic tumor in the liver was taken medicine of the present invention after 46 days, patient's ordinary circumstance can, no hepatalgia, no fear of cold, discomforts such as nothing heating, vital sign is steady.
From above-mentioned table and in the middle of the case as can be known, 1, the present invention treats the medicine new therapy of hepatocarcinoma, surmounts routine, and is novel unique.2, according to the prepared pure Chinese medicinal preparation of this therapy, clinical verification divides the card opinion to control, and has curative effect, the new drug that provides the pure Chinese medicine of brand-new therapy and unprecedented curative effect to make for the world of medicine's treatment hepatocarcinoma, and series is arranged.3, clinical verification, this invention medicine also can effectively prevent the transfer of hepatoma carcinoma cell except without any side effects, diffusion.4, this invention medicine, the medicine source is extensive, and preparation method is easy should go.5, clinical drug checking of the present invention, the effective percentage of treatment hepatocarcinoma is up to 96.6%, and obvious effective rate reaches 83%, and clinical cure rate reaches 53%, is pioneer's strength product in human treatment's hepatocarcinoma field.
The specific embodiment
Take by weighing clean material by following weight proportion:
30 parts of 20 parts of PINGDIMU of 6 parts of Radix Et Rhizoma Rhei of gallbladder powder
20 parts of 10 parts of Radix Rhapontici of 20 parts of Fossilia Spiriferiss of Concha Arcae
30 parts of 20 portions of Herba Scutellariae Barbataes of 20 portions of Ganodermas of Herba Artemisiae Scopariae
20 parts of 10 parts of Squama Maniss of 10 parts of Olibanums of Rhizoma Curcumae
20 parts of 20 parts of Herba Hedyotidis Diffusaes of Radix Knoxiae
20 parts of 5 parts of Radixs Astragali of Radix Salviae Miltiorrhizae
A, take by weighing each raw material by recipe ratio; B, with above 16 herbal medicines with the water logging of 10 times of amounts bubble 120 minutes; C is put frying pan or decocting machine with soaked medicine together with water, decoct with high heat earlier 100 degrees centigrade 15-20 minute, use slow fire boiling 40-50 minute then; Be cooled to below 40 degrees centigrade the narrow juice in back, get clear liquid after removing slag, clarifying; D, clear liquid is concentrated 2/3 make unguentum, or clear liquid was put into 80-90 degree centigrade of drying baker inner drying 8-9 hour, take out the back and pulverize, make powder or electuary or pill; E, the powder made dress sealed into the capsule of 0.5g/ grain.
Claims (6)
1, a kind of medicine for the treatment of hepatocarcinoma is characterized in that it is made by following raw materials by weight proportions:
Gallbladder powder 4-9 part Radix Et Rhizoma Rhei 14-26 part PINGDIMU 24-34 part
Concha Arcae 14-26 part Fossilia Spiriferis 6-14 part Radix Rhapontici 14-26 part
Herba Artemisiae Scopariae 14-26 part Ganoderma 14-26 part Herba Scutellariae Barbatae 24-34 part
Rhizoma Curcumae 6-14 part Olibanum 6-14 part Squama Manis 14-26 part
Radix Knoxiae 14-26 part Herba Hedyotidis Diffusae 14-26 part
Radix Salviae Miltiorrhizae 11-19 part Radix Astragali 14-26 part.
2, the medicine of treatment hepatocarcinoma according to claim 1, wherein each crude drug ratio range is:
Gallbladder powder 5-8 part Radix Et Rhizoma Rhei 16-24 part PINGDIMU 26-32 part
Concha Arcae 16-24 part Fossilia Spiriferis 8-12 part Radix Rhapontici 16-24 part
Herba Artemisiae Scopariae 16-24 part Ganoderma 16-24 part Herba Scutellariae Barbatae 26-32 part
Rhizoma Curcumae 8-12 part Olibanum 8-12 part Squama Manis 16-24 part
Radix Knoxiae 16-24 part Herba Hedyotidis Diffusae 16-24 part
Radix Salviae Miltiorrhizae 13-17 part Radix Astragali 16-24 part.
3, the medicine of treatment hepatocarcinoma according to claim 1, wherein each crude drug weight proportion is:
30 parts of 20 parts of PINGDIMU of 6 parts of Radix Et Rhizoma Rhei of gallbladder powder
20 parts of 10 parts of Radix Rhapontici of 20 parts of Fossilia Spiriferiss of Concha Arcae
30 parts of 20 portions of Herba Scutellariae Barbataes of 20 portions of Ganodermas of Herba Artemisiae Scopariae
20 parts of 10 parts of Squama Maniss of 10 parts of Olibanums of Rhizoma Curcumae
20 parts of 20 parts of Herba Hedyotidis Diffusaes of Radix Knoxiae
20 parts of 5 parts of Radixs Astragali of Radix Salviae Miltiorrhizae.
4,, it is characterized in that said gallbladder powder is to be refined by the bile of duck, goose, pig, cattle to form according to the medicine of claim 1 or 2 or 3 described treatment hepatocarcinoma.
5,, it is characterized in that said medicine is unguentum or powder or capsule or pill according to the medicine of claim 1 or 2 or 3 described treatment hepatocarcinoma.
6, the preparation method of the medicine of treatment hepatocarcinoma according to claim 1 is characterized in that: a, take by weighing each raw material by recipe ratio; B, with above 16 herbal medicines with the water logging of 10 times of amounts bubble 120 minutes; C is put frying pan or decocting machine with soaked medicine together with water, decoct with high heat earlier 100 degrees centigrade 15-20 minute, use slow fire boiling 40-50 minute then; Be cooled to below 40 degrees centigrade the narrow juice in back, get clear liquid after removing slag, clarifying; D, clear liquid is concentrated 2/3 make unguentum, or clear liquid was put into 80-90 degree centigrade of drying baker inner drying 8-9 hour, take out the back and pulverize, make powder or electuary or pill; E, the powder made dress sealed into the capsule of 0.5g/ grain.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008101431663A CN101357206A (en) | 2008-09-02 | 2008-09-02 | Medicine for treating liver cancer and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008101431663A CN101357206A (en) | 2008-09-02 | 2008-09-02 | Medicine for treating liver cancer and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101357206A true CN101357206A (en) | 2009-02-04 |
Family
ID=40329892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2008101431663A Pending CN101357206A (en) | 2008-09-02 | 2008-09-02 | Medicine for treating liver cancer and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101357206A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102091302A (en) * | 2011-03-17 | 2011-06-15 | 南京中医药大学 | Compound traditional Chinese medicine with anti-hepatocarcinoma effect and application thereof |
| CN101757560B (en) * | 2009-12-16 | 2013-02-27 | 张�林 | Medicament for treating liver cancer and preparation method thereof |
| CN111012886A (en) * | 2020-01-14 | 2020-04-17 | 李天基 | Medicine for treating liver cancer and preparation method thereof |
-
2008
- 2008-09-02 CN CNA2008101431663A patent/CN101357206A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101757560B (en) * | 2009-12-16 | 2013-02-27 | 张�林 | Medicament for treating liver cancer and preparation method thereof |
| CN102091302A (en) * | 2011-03-17 | 2011-06-15 | 南京中医药大学 | Compound traditional Chinese medicine with anti-hepatocarcinoma effect and application thereof |
| CN111012886A (en) * | 2020-01-14 | 2020-04-17 | 李天基 | Medicine for treating liver cancer and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103071128B (en) | Externally-applied plaster for curing dysmenorrhea | |
| CN101632827B (en) | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof | |
| CN102641434A (en) | Capsule capable of promoting blood circulation, removing meridian obstruction and removing paralysis and preparing technology thereof | |
| CN103127422B (en) | Medicament for treating ulcerative colitis | |
| CN102688420A (en) | Traditional Chinese medicine decoction for treating psoriasis | |
| CN102188685B (en) | Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof | |
| CN101357202A (en) | Chinese traditional medicine for treating hepatosis and preparation method thereof | |
| CN101357206A (en) | Medicine for treating liver cancer and preparation method thereof | |
| CN103301315B (en) | Medicament for treating gastric ulcer | |
| CN102526620B (en) | Traditional Chinese medicinal composition for treating gynecological inflammation and application of same | |
| CN102240302B (en) | Chinese medicine composition of super gene active peptide | |
| CN101549138B (en) | Acne treating Chinese medicine preparation and method of producing the same | |
| CN101816745B (en) | Chinese medicine composite applicable to treating ascitesduetocirrhosis and preparation method thereof | |
| CN104013816A (en) | Pharmaceutical composition for treating esophagus cancer | |
| CN103054981A (en) | External traditional Chinese medicine for treating abdominal malignant tumours | |
| CN102488804B (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN101129718B (en) | Traditional Chinese medicine preparation for treating leuoderma | |
| CN104027447A (en) | Traditional Chinese medicine for treating cancer | |
| CN104043024A (en) | Traditional Chinese medicine composition for treating qi depression type abdominal mass | |
| CN102772763B (en) | Traditional Chinese medicinal composition for resisting tumor metastasis and method for preparing traditional Chinese medicinal composition | |
| CN102389477A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
| CN102727854B (en) | Traditional Chinese medicine for treatment of gastric cancer | |
| CN102380023A (en) | Chinese medicament for treating benign prostatic hyperplasia | |
| CN101693096A (en) | Medicament for treating liver cancer and preparation method thereof | |
| CN105435015A (en) | Traditional Chinese medicine for treating acute pancreatitis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20090204 |
|
| C20 | Patent right or utility model deemed to be abandoned or is abandoned |